EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study

Hao Ling iD, Peiyu Qiu, Yanzhu Hu, Yan Sun iD

International Journal of Molecular Sciences · 18.08.2026 · 27 (16) · 7387

DOI: 10.3390/ijms27167387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2026. Verfasst von Hao Ling und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany. Hauptthemen laut MEDLINE: Cyclic AMP Response Element Modulator, Thyroid Cancer, Papillary, Lymphocyte Activation, Thyroid Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although papillary thyroid carcinoma (PTC) is widely considered an immunologically cold tumor, detectable T-cell infiltration can influence disease progression in selected patients. Previous bulk analyses have linked cAMP-responsive element modulator (CREM) expression to a favorable progression-free interval and an inverse correlation with regulatory T-cell infiltration but have not resolved the cellular origin or functional state. In this study, we integrate single-cell RNA-sequencing data from a 23-sample PTC atlas with bulk Cancer Genome Atlas Thyroid Carcinoma (TCGA–THCA) validation. We show that CREM marks a T-cell receptor (TCR)-driven immediate early gene activation state in tumor-infiltrating T cells rather than a cAMP program; this state is consistently and modestly enriched within the FOXP3+ regulatory T-cell compartment, challenging the interpretation that bulk inverse Treg–CREM correlations reflect Treg-intrinsic repression. CREM-high T cells upregulate ANXA1, and permutation-controlled analysis identifies a candidate paracrine axis from CD4/CD8 T cells to the epithelial epidermal growth factor receptor (EGFR). At the bulk level, CREM expression correlates with reduced proliferation programs and is associated with a prolonged progression-free interval (multivariate HR 0.56, 95% CI 0.31–1.00, p = 0.050), with the effect direction preserved after immune and sex adjustment. Genome-wide differential expression and gene-set enrichment in an independent cohort (GSE193581) confirm that CREM-detected T cells are enriched for a TCR-driven immediate early transcriptional program, supporting the reinterpretation of CREM as a marker of TCR-driven IEG activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic AMP Response Element ModulatorThyroid Cancer, PapillaryLymphocyte ActivationThyroid NeoplasmsReceptors, Antigen, T-CellTranscriptomeHumansPrognosisGene Expression Regulation, NeoplasticSingle-Cell Analysis

Stichwörter der Autor:innen

ANXA1NR4AT-cell activationcAMP-responsive element modulator (CREM)immediate early genespapillary thyroid carcinomaprogression-free interval

Substanzen

Cyclic AMP Response Element ModulatorReceptors, Antigen, T-CellCREM protein, human

Autor:innen und Institutionen

  • Department of Surgery, Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
  • Department of Respiratory Medicine, Institute for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
  • Department of Genetics & Cell Biology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Institute for Oncology and Reproduction (GROW), Maastricht University, 6229 ER Maastricht, The Netherlands.

ORCID-Profile: Hao Ling, Yan Sun

Zitieren

APA

Ling, H., Qiu, P., Hu, Y., & Sun, Y. (2026). CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study. International Journal of Molecular Sciences, 27(16), 7387. https://doi.org/10.3390/ijms27167387

Vancouver

Ling H, Qiu P, Hu Y, Sun Y. CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study. International Journal of Molecular Sciences. 2026;27(16):7387. doi:10.3390/ijms27167387

BibTeX
@article{Ling2026,
  author = {Ling, Hao and Qiu, Peiyu and Hu, Yanzhu and Sun, Yan},
  title = {CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7387},
  doi = {10.3390/ijms27167387}
}
Kostenlos starten →